씨어스테크놀로지
458870KOSDAQ의료용 기기 제조업46.2 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
Seers Technology provides IoMT platform services using AI algorithms and wearable medical devices, including mobiCARE™ for ECG analysis and thynC™ for inpatient monitoring. mobiCARE™, launched in 2020, is used by over 1,000 medical institutions with 620,000 test cases, while thynC™, launched in 2024, has achieved 12,000 installed beds. Key products include certified wearable medical devices such as ECG monitors and thermometers.
Number of Employees
130people
Average Salary
74.1M KRW
Score Calculation Basis
Detailed Financial Score
4.1x industry avg (risky)
8.7x industry avg (risky)
6.6x industry avg (excellent)
In line with industry avg
Avg ▲494.7% (1-year basis)
Avg ▲288.1% (1-year basis)
Avg ROE -3.8% (improving, 2yr)
Detailed News Sentiment
- Neutral“코스닥 판 바뀐다…액티브 ETF로 ‘제2의 엔비디아’ 발굴”
한화자산운용 매니저가 코스닥 시장에서 AI 혁신 기업 발굴의 중요성을 강조했습니다.
- Positive씨어스테크놀로지, 임직원 3명에 스톡옵션 15만주 부여
씨어스테크놀로지가 임직원 3명에게 스톡옵션 15만주를 부여했습니다.
- Positive흑자 달성 '씨어스'…새 이름 달고 해외 영토확장 나선다
씨어스테크놀로지가 사명을 'SEERS'로 변경하고 글로벌 디지털 헬스케어 플랫폼 기업으로 도약할 계획입니다.
Detailed Momentum
Near 52w low (19%, downtrend)
1m -71.20% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-10
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-10
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-10
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-10
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-10
